KANES STEPHEN (Chief Medical Officer) received a stock award from CENTESSA PHARMACEUTICALS PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001470831-26-000098
Officer· Chief Medical Officer
Since Feb 2026
+120K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
120K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+120K
Price / share
—
Trade value
—
% of position
New position
2/2/2026
0.00→120K
Total
Net shares
+120K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/2/2026 | A · Award | +120K | — | — | New position | 0.00 | 120K |
| Total | +120K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported